A drug with the SMILES CCN(CC)CCn1c2c(c(SCC(=O)Nc3nc4ccccc4s3)nc1=O)CCCC2 has a human ether-à-go-go related gene (hERG) inhibition at 1uM of -10.442\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CCN(CC)CCn1c2c(c(SCC(=O)Nc3nc4ccccc4s3)nc1=O)CCCC2
CCN(CC)CCn1c2c(c(SCC(=O)Nc3nc4ccccc4s3)nc1=O)CCCC2
N-(1,3-benzothiazol-2-yl)-2-[[1-[2-(diethylamino)ethyl]-2-oxo-5,6,7,8-tetrahydroquinazolin-4-yl]sulfanyl]acetamide